US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

C-Dexamethasone 24mg/Ml Inj Solution

Reason Lack of Assurance of Sterility: product sterility cannot be guaranteed.

Colonia Care Pharmacy D-0009-2020
Class II · Moderate risk Terminated

C-Calcium Glucnate 1% Injection Soln

Reason Lack of Assurance of Sterility: product sterility cannot be guaranteed.

Colonia Care Pharmacy D-0007-2020
Class II · Moderate risk Terminated

C-Atropine Sulf Ophth 0.02%

Reason Lack of Assurance of Sterility: product sterility cannot be guaranteed.

Colonia Care Pharmacy D-0006-2020
Class II · Moderate risk Terminated

C-Atropine Sulf Ophth 0.01%

Reason Lack of Assurance of Sterility: product sterility cannot be guaranteed.

Colonia Care Pharmacy D-0005-2020
Class II · Moderate risk Terminated

C-Albumin 5% Ophth Solution

Reason Lack of Assurance of Sterility: product sterility cannot be guaranteed.

Colonia Care Pharmacy D-0004-2020
Class II · Moderate risk Terminated

C-Acetylcysteine Ophth 10% Soln

Reason Lack of Assurance of Sterility: product sterility cannot be guaranteed.

Colonia Care Pharmacy D-0003-2020
Class II · Moderate risk Terminated

Mometasone Furoate Cream USP

Reason GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty.

Glenmark Pharmaceuticals Inc., USA NDC 68462-192-17 D-1586-2019
Class II · Moderate risk Terminated

Gentamicin

Reason Lack of Processing Controls

Wise Pharmacy D-1570-2019
Class II · Moderate risk Terminated

Acetylcysteine 2% Otic Drop

Reason Lack of Processing Controls

Wise Pharmacy D-1567-2019
Class II · Moderate risk Terminated

Lisinopril and Hydrochlorothiazide Tablets USP

Reason Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.

Lupin Pharmaceuticals Inc. NDC 68180-519-02 D-1581-2019
Class II · Moderate risk Terminated

Monsel's

Reason Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contamination in addition to high out of specification results for iron content.

Dercher Enterprises, Inc., DBA Gordon Laboratories NDC 10481-0112-8 D-1528-2019
Class II · Moderate risk Terminated

Keppra

Reason Failed Dissolution Specifications.

Ucb, Inc NDC 50474-597-66 D-1838-2019
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection USP

Reason Lack of Assurance of Sterility: Bags have potential to leak.

Baxter Healthcare Corporation NDC 0338-0049-38 D-1514-2019
Class II · Moderate risk Terminated

Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10

Reason CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.

Preferred Pharmaceuticals, Inc NDC 68788-9373-03 D-1491-2019